ArticleTechnical innovations & patient support in radiation oncology2026
Version upgrades in treatment planning Systems affect clinical application of a multi-Centre knowledge-based planning model.
Article in Technical innovations & patient support in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To determine if version upgrades to treatment planning system software have an impact on the clinical application of a knowledge-based planning model built in a previous version. Methods: Twenty patients' data sets treated for prostate cancer were retrospectively selected for planning on three different versions of Eclipse (Varian Medical Systems) treatment planning system, (Vn13.6, Vn15.6, Vn16.1) using a multi-centre RapidPlan model that was built in Vn13.6. Each plan was created using identical beam arrangement, and optimisation objectives and calculation settings. The RapidPlan model was also re-trained in Vn15.6 and Vn16.1 and the datasets were replanned using these models with the same method. Results: Seven plan comparisons were performed, evaluating four target metrics and eight organ at risk (OAR) metrics. Statistically significant differences to median values for target dose metrics were observed in 10 out of 28 plan comparisons and for OARs in 23 out of 56 plan comparisons. Re‑extracted and re‑trained models in Vn15.6 and Vn16.1 improved target coverage and several OAR dose metrics. Small increases were observed in some OAR metrics for a subset of plans using the Vn15.6 model; however, the largest variations were minor (≤1.4%), including Bladder_65Gy (<1.3%), Bladder_70Gy (<0.7%), Rectum_65Gy (<0.9%), and Rectum_70Gy (<1.4%). Conclusion: Eclipse version upgrades will have varying effects on the resultant plans optimised using a RapidPlan models developed and trained in earlier versions. This study confirms the recommendation from the vendor that it is important to re-extract and re-train RapidPlan models when an Eclipse version upgrade is undertaken to ensure optimal dosimetry is achieved.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.